Is transdermal nitroglycerin application effective in preventing and healing flap ischaemia after modified radical mastectomy?
|Article Type:||Letter to the editor|
(Dosage and administration)
Transdermal medication (Usage)
Ischemia (Drug therapy)
|Publication:||Name: South African Journal of Surgery Publisher: South African Medical Association Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2011 South African Medical Association ISSN: 0038-2361|
|Issue:||Date: Nov, 2011 Source Volume: 49 Source Issue: 4|
|Product:||Product Code: 2868796 Nitroglycerine; 2834032 Transdermal Drug Delivery Sys NAICS Code: 32592 Explosives Manufacturing; 325412 Pharmaceutical Preparation Manufacturing SIC Code: 2892 Explosives; 2834 Pharmaceutical preparations|
|Geographic:||Geographic Scope: South Africa Geographic Code: 6SOUT South Africa|
To the Editor: We read the article by Kutun et al. on the use of
transdermal nitroglycerin application in preventing and healing flap
ischaemia after modified radical mastectomy with interest. (1) Although
we do not dispute the numerous attributes of nitroglycerin, we would
like to voice some concerns and highlight certain relevant issues not
discussed by the authors in this paper.
We are surprised that during the study period no breast-conserving surgery (BCS) was performed in a large cohort of patients treated for early breast cancer (stage II). It is well documented that despite trends toward breast-conserving surgery for breast cancer, a significant number of women are still subjected to mastectomy as their primary surgical therapy. This figure, however, is never 100%. (2,3)
Mastectomy is associated with significant skin flap complications, with a prevalence ranging from 18% to 30% (average 26%). These increase morbidity and healthcare costs, result in prolonged hospitalisation, and delay the initiation of adjuvant therapy (chemotherapy or radiotherapy).
It is known that blood perfusion to the subdermal plexus of the skin is controlled by the autonomic nervous system in response to variations in metabolic demands and environmental factors. (2) The authors are correct in stating that temperature, tissue perfusion and neural stimuli can affect flap perfusion and thus complication rates. However, it remains important to ensure that the blood supply to the subdermal plexus is not compromised. In this respect it is important to understand risk factors for flap necrosis and to abide by simple surgical principles.
Wound morbidity following mastectomy is related to the creation of large thin flaps, and the use of cautery. Very thin flaps should be avoided, as they tend to develop necrosis. A flap thickness of 5 mm is recommended. Flap thickness refers to the measurement of the skin flap at its most distal aspect. There is currently no standardised method for measuring mastectomy skin flap thickness intra-operatively, and this remains a surgical judgement call. The use of calipers may be helpful.
Flap length usually refers to the superior flap length, as this is typically the longest flap in a mastectomy. Longer flap length is associated with flap necrosis, consistent with the concept that the blood supply of longer flaps is more tenuous, probably owing to the greater area of vascular disruption required when a mastectomy is performed. Excessively long flaps should be avoided, as should wound closure under tension. Careful pre-operative planning will identify patients at risk for large defects and facilitate the planning of autologous tissue cover.
Evidence suggests that the use of cautery is associated with an increase in the incidence of flap necrosis. Increased thrombosis of subdermal vessels caused by cautery results in relative ischaemia of skin flaps. (3)
Furthermore, wound healing is a complicated process. Factors contributing to or complicating the wound healing process include body habitus, age, co-morbidities, prolonged operative time, collagen disorders, infection, past radiation exposure, immune status and steroid use. The authors' findings of significantly higher complication rates in those patients with co-morbidities are therefore not surprising. However, it is unclear whether nitroglycerin was beneficial in this cohort of patients, as the majority of patients with diabetes mellitus and hypertension fell into the control group.
There is currently no standard for evaluating skin flaps intraoperatively and no method to quantitatively evaluate mastectomy skin perfusion. Techniques currently utilised to evaluate mastectomy flap viability intra-operatively range from crude, subjective methods such as detection of skin discoloration, evaluation of 'bleeding edges' and assessment of capillary refill, to more sophisticated methods: the intravenous sodium fluorescein test (Wood's lamp method), near-infrared spectroscopy and transcutaneous electrical nerve stimulation (TENS). (4)
Without detracting from the authors' conclusion that nitroglycerin is successful in minimising post-mastectomy skin flap complications, with the added benefits of being cost-effective, safe and acceptable to patients, it is our considered opinion that this is a tedious method and probably not reproducible outside their centre.
Departments of Surgery and Plastic & Reconstructive Surgery
Nelson R. Mandela School of Medicine
University of KwaZulu-Natal
(1.) Kutun S, Ay AA, Ulucanlar H, et al. Is transdermal nitroglycerin application effective in preventing and healing flap ischemia after modified radical mastectomy? S Afr J Surg 2010;48(4):119-121.
(2.) Rao R, Saint-Cyr M, Ma AMT, et al. Prediction of post-operative necrosis after mastectomy: A pilot study utilizing optical diffusion imaging spectroscopy. World Journal of Surgical Oncology 2009;7(91). Published on-line 25 November 2009. doi: 10.1 186/1477-7819-7-91.
(3.) Wu Hongying, Zhang Chun Shan, Thakur B. Origin and countermeasure for common skin flap complications after radical operation for breast cancer. Kathmandu University Medical Journal 2006;4(No.1, Issue 13):14-17.
(4.) Yilmaz AC. The effect of transcutaneous electrical nerve stimulation on postmastectomy skin flap necrosis. Breast Cancer Res Treat 2009;117(3):611-614.
|Gale Copyright:||Copyright 2011 Gale, Cengage Learning. All rights reserved.|